InMed Pharmaceuticals Inc. (26)
Browse by Contract Category
Contracts
-
Form of Public Warrant
(Filed With SEC on November 12, 2020)
-
July 3, 2019 salary adjustment letter to Eric Hsu
(Filed With SEC on July 6, 2020)
-
Amended and Restated Executive Employment Agreement, dated April 8, 2020, between Eric A. Adams and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
Office Premises Lease, dated January 14, 2019, between InMed Pharmaceuticals Inc. and 815 West Hastings Ltd
(Filed With SEC on June 19, 2020)
-
Underwriting Agreement, dated November 12, 2020, by and between InMed Pharmaceuticals Inc. and Roth Capital Partners, LLC, as representative of the underwriters named therein
(Filed With SEC on November 12, 2020)
-
Form of Public Warrant
(Filed With SEC on October 8, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 8, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on September 15, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on July 6, 2020)
-
July 3, 2019 salary adjustment letter to Michael Woudenberg
(Filed With SEC on July 6, 2020)
-
April 13, 2018 salary adjustment letter to Eric Hsu
(Filed With SEC on June 19, 2020)
-
Technology Assignment Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
InMed Pharmaceuticals Inc. 2017 Stock Option Plan
(Filed With SEC on June 19, 2020)
-
Form of Stock Option Agreement pursuant to the InMed Pharmaceuticals Inc. 2017 Stock Option Plan
(Filed With SEC on June 19, 2020)
-
Amended and Restated Collaborative Research Agreement, dated as of August 16, 2018, between The University of British Columbia and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
Collaborative Research Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
Amendment No. 1 to Technology Assignment Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
Assignment of Intellectual Property, dated as of October 28, 2015, between Dr. Sazzad Hossain and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
September 1, 2018 salary adjustment letter to Eric Hsu
(Filed With SEC on June 19, 2020)
-
Section 85 Purchase and Sale Agreement, dated as of October 28, 2015, between Dr. Sazzad Hossain and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
Share Purchase Agreement, dated May 10, 2014, among Meridex Software Corporation, Biogen Sciences Inc. and the Shareholders of Biogen Sciences Inc
(Filed With SEC on June 19, 2020)
-
Employment Agreement, dated March 8, 2018, between Eric Hsu and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
Executive Employment Agreement, dated July 9, 2019, between Bruce S. Colwill and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
Executive Employment Agreement, dated September 20, 2018, between Michael Woudenberg and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
Amended and Restated Executive Employment Agreement, dated April 8, 2020, between Alexandra Mancini and InMed Pharmaceuticals Inc
(Filed With SEC on June 19, 2020)
-
March 4, 2019 salary adjustment letter to Eric Hsu
(Filed With SEC on June 19, 2020)